Metraipolis › archive › dc_8d6aef10470e
ZW4864-mediated inhibition of the β-catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer — Europe PMC PMID:42316797
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42316797
- DOI
- 10.1002/1878-0261.70292
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T08:41:41.306Z
- SHA-256 of the archived text
0610d16eaff60631c8973815f626417a1fbc75f7ef922fcfbdbe175c1e4c6e6f- Stable URL of this page
https://metraipolis.com/documento/dc_8d6aef10470e
How to cite
ZW4864-mediated inhibition of the β-catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer — Europe PMC PMID:42316797 — Europe PMC (en), https://europepmc.org/article/MED/42316797 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8d6aef10470e (Metraipolis archive dc_8d6aef10470e, sha256 0610d16eaff60631c8973815f626417a1fbc75f7ef922fcfbdbe175c1e4c6e6f)
BibTeX
@misc{dc8d6aef10470e,
title = {ZW4864-mediated inhibition of the β-catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer — Europe PMC PMID:42316797},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42316797},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8d6aef10470e; sha256 0610d16eaff60631c8973815f626417a1fbc75f7ef922fcfbdbe175c1e4c6e6f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42316797. Agents can read the archived copy with the MCP tool read_document.